fda tirzepatide injection shortage resolved oct 2 2024 says the weight-loss drug is over Food and Drug Administration Reconfirms – fda tirzepatide injection shortage resolved

When you take the medication at the same time every week, the concentration levels remain relatively stable

Deep Dive: The GLP-1 Impact Background: Starting Tirzepatide (April 2024) In April 2024, I started Tirzepatide (Mounjaro/Zepbound) at 2.5mg, gradually escalating to 10mg over several months

Case reports have been published highlighting unusual cutaneous side effects of GLP-1RAs, including injection site nodules, alopecia, and altered skin sensations that clinicians should be aware of

The Centers for Disease Control and Prevention (CDC) estimates that more than 40% of US adults have obesity and 11% have diabetes (National Center for Health Statistics, 2023